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Obligate anaerobic bacteria are important members of the normal human microbiota,
present in high numbers on mucosal surfaces (e.g., the oral cavity, female genital tract,
and colon), outnumbering other bacteria 10–1000-fold [1]. Anaerobic bacteria have been
implicated in a wide range of infectious processes from almost all anatomical sites, by
bacteria from both exogenous (e.g., toxin-mediated pathologies by Clostridia) and endoge-
nous (displacement of the bacterial flora to other anatomical regions) sources [2]. These
pathogens may be important etiological agents in life-threatening, invasive infections [3,4].
The cultivation and identification of strict anaerobes is labor-intensive and requires ex-
pertise and special laboratory conditions and equipment; therefore, for many years, only
several anaerobes were considered clinically relevant [5]. With the emergence and spread
of modern identification technologies—such as polymerase chain reaction (PCR), matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS),
and 16S RNA gene sequencing—in clinical microbiology laboratories, the pathogenic role
of these microorganisms may be established more realistically [6].
Non-spore-forming Gram-positive anaerobes include the genera Actinomyces, Arachnia,
Bifidobacterum, Bryantella, Cutibacterium (previously Propionibacterium), and Eubacterium [7].
The genus name “Actinomyces” originates from the Greek words “aktina” («ακτίνα») (ray)
and “mykis” («µύκης») (fungus), which aims to symbolize the arrangement of the bacterial
filaments, which may frequently be observed with microscopy [8]. As of now, there have
been 26 individual Actinomyces species implicated in human clinical infections (actino-
mycoses), with A. odontolyticus, A. meyeri, A. israelii, and A. gerencseriae responsible for
more than 90% of these infections [9,10]. Most cases (40–60%) of actinomycoses affect the
cervicofacial region and the central nervous system (CNS), while abdominal (20–30%),
thoracic/pulmonary (20–30%), pelvic (3–5%), and cutaneous (3–5%) manifestations must
also be considered [9–13]. The clinical diagnosis of actinomycosis may be quite difficult:
the clinical presentation of the patient, past medical history (injuries, immunosuppression,
cancers), laboratory parameters, microbiological culture, and histopathology must all be
taken into consideration, as this disease frequently mimics a malignancy or infection by
other bacteria (e.g., Nocardia, mycobacteria) [11–13]. Nonetheless, successful culture is
also hindered by the slow growth rate and fastidious growth requirements of Actinomyces
species [6,9].
Although actinomycoses are thought to be rarely occurring infections, there is very
limited data available on their epidemiology: the prevalence of actinomycoses has been
estimated to be around 1/300,000 persons, but this estimation is largely outdated [14].
This may be due to, among other things, the fact that actinomycoses are not included in
the World Health Organization (WHO) Recommended Surveillance Standards or in the
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national bacteriological surveillance of many countries. As up-to-date references were
scarce on the topic of Actinomyces infections, the Special Issue “Microbiological and Clinical
Aspects of Actinomyces Infections” was established with the aim of enriching the existing
literature regarding these neglected pathogens with original articles, case reports, and
comprehensive review papers. In the following section, we would like to present a short
summary of the papers published in our Special Issue to prompt further interest in these
articles.
Gajdács et al. performed a much-needed summary of the currently available literature
on the pathogenic role of Actinomyces species and Actinomyces-like organisms (ALOs) in
the female and male genital tract (genital tract actinomycosis is the second most common
manifestation of the disease) and in urinary tract infections (UTIs), in addition to infections
associated with intrauterine devices (IUDs). The review also contained a separate section
concerning the antibiotic therapy and antibiotic resistance (including the production of
blaTEM-type β-lactamases and reduced membrane permeability) of Actinomyces species and
ALOs [15].
Džupová et al. described the case of a 35-year-old female patient with disseminated
pelvic actinomycosis secondary to an IUD [16]. The patient postponed seeking medical
attention due to fears of repercussions in the workplace and fears of a tumor diagnosis.
After a battery of laboratory tests (which did not confirm the presence of immunosup-
pression or HIV), computer tomography (CT), and a biopsy, the diagnosis of metastatic
ovarian cancer was assumed; in addition, bilateral ureteral stricture was also detected.
Interestingly, the involvement of actinomycosis (A. naeslundii) was only revealed after the
examination of a liver biopsy sample. In addition, the principal symptoms of the patient
were prolonged exhaustion, malaise, and cachexia, while the signs on the affected tissues
were only noticeable much later on. The patient underwent extensive surgery, the IUD was
removed, and she received antibiotic therapy for nine months. This case highlights the
difficulties of differential diagnosis (actinomycosis vs. malignancy), in addition to the renal
involvement, which is frequently noted in pelvic actinomycosis [16].
Chaves et al. described a case of pulmonary actinomycosis in a 35-year-old female
with bronchopulmonary sequestration, who had complaints of dyspnea and persistent
coughing and a 4-year history of recurrent pneumonia [17]. During the clinical workup, a
CT scan of the chest revealed a multicystic mass vascularized by an aberrant vessel in the
left lung of the patient, which prompted the clinicians to perform surgery. Just before the
procedure, the patient had a high white blood cell (WBC) count with neutrophil dominance.
During the surgery, a lung fragment was extracted, which was sent for histopathological
examination: here, filamentous nonsporulating bacilli were seen, which were identified as
Actinomyces spp. (via histological staining, sulfur granules). Interestingly, as the patient
was asymptomatic at the time and the laboratory parameters were close to the normal
range, no antibiotic therapy was ordered [17].
D’Amore et al. presented a case of lingual actinomycosis in a 52-year-old male patient,
complaining of a recent, asymptomatic, nonulcerated swelling of the anterior part of
the tongue [18]. The patient reportedly had a benign squamous papilloma on the same
location of this tongue 5 years prior. Laboratory tests indicated neutropenia, monocytosis,
and elevated C-reactive protein (CRP) levels. During the biopsy (for histopathological
diagnosis), a yellowish purulent discharge was noted. This, together with the histological
examination of the sample, led to the diagnosis of actinomycosis of the tongue. The patient
received clarithromycin for seven days, as he had a known penicillin allergy. Overall, the
patient was complaint-free after the short course of antibiotics [18].
Stájer et al. described two distinct clinical cases of cervicofacial actinomyces infections
with the antibiotic susceptibilities of the implicated pathogens; in addition, the authors pro-
vided an epidemiological summary of cervicofacial infections in their institution between
2005 and 2015 [19]. The first case was from a 22-year-old female patient who was of high
social status and had generally good oral and personal hygiene; the patient had no known
underlying conditions except for penicillin allergy. Based on the clinical presentation, the
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presumptive diagnosis of cervicofacial actinomyces was established, and samples were sent
to the microbiology department. The samples were positive for A. israelii, Clostridium ramo-
sum, C. clostridioforme, Prevotella bivia (strict anaerobes), Capnocytophaga spp., and Eikenella
corrodens (facultative anaerobes). The patient received clindamycin and metronidazole
for seven days, with instructions to take clindamycin for an additional seven days. In
contrast, the authors described a second, more complicated case of a 40-year-old patient
from a low socioeconomic standing with neglected oral hygiene, following a traumatic
injury. Following surgical intervention, the patient received amoxicillin, but the adherence
of the patient was unsatisfactory. Six months later, the patient returned with pain and
swelling in the area of the previous injury and partial trismus. After an incision was made,
a sample for culture was sent to the microbiology laboratory, which reported A. israelii
in high colony counts. The infected surgical site was drained, and the patient received
amoxicillin intravenously and later per os. The highlight of the present article is that
cervicofacial actinomyces infections are rare, but they must be considered in patients from
all different backgrounds and medical histories [19].
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